Intraveous gammaglobulin in systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoinmune multisystemic disease. Intravenous immunoglobulins (IVIg) have been previously used for the treatment of primary immunodefi- ciency diseases. In addition IVIg is used for a few autoimmune diseases, such as immune thrombocytopenic purpura. IV...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Instituto Nacional de Pediatría,
2014-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Systemic lupus erythematosus (SLE) is a chronic autoinmune multisystemic disease. Intravenous immunoglobulins (IVIg) have been previously used for the treatment of primary immunodefi- ciency diseases. In addition IVIg is used for a few autoimmune diseases, such as immune thrombocytopenic purpura. IVIg is an immunomodulatory agent capable of modulating autoinmu- nity and also provide defense against infection, IVIg has been used successfully in SLE. We review the role of IVIg in SLE as a therapeutic option. |
|---|---|
| Item Description: | 0186-2391 2395-8235 10.18233/APM34No6pp353-357 |